Transcription Factors in Eosinophil Development and As Therapeutic Targets
Dynamic gene expression is a major regulatory mechanism that directs hematopoietic cell fate and differentiation, including eosinophil lineage commitment and eosinophil differentiation. Though GATA-1 is well established as a critical transcription factor (TF) for eosinophil development, delineating...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-07-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00115/full |
id |
doaj-d52315991877465f836ce9c23c7a252f |
---|---|
record_format |
Article |
spelling |
doaj-d52315991877465f836ce9c23c7a252f2020-11-25T00:20:28ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2017-07-01410.3389/fmed.2017.00115281143Transcription Factors in Eosinophil Development and As Therapeutic TargetsPatricia C. Fulkerson0Division of Allergy and Immunology, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United StatesDynamic gene expression is a major regulatory mechanism that directs hematopoietic cell fate and differentiation, including eosinophil lineage commitment and eosinophil differentiation. Though GATA-1 is well established as a critical transcription factor (TF) for eosinophil development, delineating the transcriptional networks that regulate eosinophil development at homeostasis and in inflammatory states is not complete. Yet, recent advances in molecular experimental tools using purified eosinophil developmental stages have led to identifying new regulators of gene expression during eosinophil development. Herein, recent studies that have provided new insight into the mechanisms of gene regulation during eosinophil lineage commitment and eosinophil differentiation are reviewed. A model is described wherein distinct classes of TFs work together via collaborative and hierarchical interactions to direct eosinophil development. In addition, the therapeutic potential for targeting TFs to regulate eosinophil production is discussed. Understanding how specific signals direct distinct patterns of gene expression required for the specialized functions of eosinophils will likely lead to new targets for therapeutic intervention.http://journal.frontiersin.org/article/10.3389/fmed.2017.00115/fullhematopoiesiseosinophilopoiesistranscriptional regulationeosinophil developmenteosinophil lineage commitment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Patricia C. Fulkerson |
spellingShingle |
Patricia C. Fulkerson Transcription Factors in Eosinophil Development and As Therapeutic Targets Frontiers in Medicine hematopoiesis eosinophilopoiesis transcriptional regulation eosinophil development eosinophil lineage commitment |
author_facet |
Patricia C. Fulkerson |
author_sort |
Patricia C. Fulkerson |
title |
Transcription Factors in Eosinophil Development and As Therapeutic Targets |
title_short |
Transcription Factors in Eosinophil Development and As Therapeutic Targets |
title_full |
Transcription Factors in Eosinophil Development and As Therapeutic Targets |
title_fullStr |
Transcription Factors in Eosinophil Development and As Therapeutic Targets |
title_full_unstemmed |
Transcription Factors in Eosinophil Development and As Therapeutic Targets |
title_sort |
transcription factors in eosinophil development and as therapeutic targets |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2017-07-01 |
description |
Dynamic gene expression is a major regulatory mechanism that directs hematopoietic cell fate and differentiation, including eosinophil lineage commitment and eosinophil differentiation. Though GATA-1 is well established as a critical transcription factor (TF) for eosinophil development, delineating the transcriptional networks that regulate eosinophil development at homeostasis and in inflammatory states is not complete. Yet, recent advances in molecular experimental tools using purified eosinophil developmental stages have led to identifying new regulators of gene expression during eosinophil development. Herein, recent studies that have provided new insight into the mechanisms of gene regulation during eosinophil lineage commitment and eosinophil differentiation are reviewed. A model is described wherein distinct classes of TFs work together via collaborative and hierarchical interactions to direct eosinophil development. In addition, the therapeutic potential for targeting TFs to regulate eosinophil production is discussed. Understanding how specific signals direct distinct patterns of gene expression required for the specialized functions of eosinophils will likely lead to new targets for therapeutic intervention. |
topic |
hematopoiesis eosinophilopoiesis transcriptional regulation eosinophil development eosinophil lineage commitment |
url |
http://journal.frontiersin.org/article/10.3389/fmed.2017.00115/full |
work_keys_str_mv |
AT patriciacfulkerson transcriptionfactorsineosinophildevelopmentandastherapeutictargets |
_version_ |
1725367496014299136 |